Primary Osseous Fibroblastic Reticular Cell Tumour of the Proximal Humerus: A Rare Case Report and Review of Pathogenesis
Primary Osseous Fibroblastic Reticular Cell Tumour
Keywords:
Oncology, Fibroblastic, Bone Tumour, HumerusAbstract
Fibroblastic reticular cell tumour (FRCT) is an exceptionally rare neoplasm arising from specialised fibroblastic reticular cells of the lymphoid stromal network. Primary involvement of bone is extraordinarily uncommon, with only isolated cases reported in the literature. We present a case of a 40-year-old woman with a destructive lesion of the proximal humerus subsequently diagnosed as FRCT. The patient was treated with neoadjuvant chemotherapy followed by wide surgical excision and endoprosthetic reconstruction. This report highlights the clinical, radiological, pathological, and therapeutic challenges associated with this rare entity and reviews emerging concepts of FRCT pathogenesis, including ectopic stromal differentiation, chemokine-driven microenvironmental mimicry, and mismatch-repair deficiency. This case contributes to the limited body of literature on primary osseous FRCT and underscores the importance of multidisciplinary management.
References
Fibroblastic Reticular Cell Tumour of the Proximal HumerusLink A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, Cyster JG, Luther SA. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol. 2007;8(11):1255-65.
Walsh H, Brierley D, Patterson A, Fernando M. A Fibroblastic Reticular Cell Tumour Arising in the Oral Cavity: A Case Report and Review of the Literature. Head Neck Pathol. 2023;17(2):534-9
Li H, Shen P, Liang Y, Zhang F. Fibroblastic reticular cell tumor of the breast: A case report and review of the literature. Exp Ther Med. 2016;11(2):561-4.
Baig Mirza A, Visagan R, Reisz Z, Bodi I, Bell D, Grahovac G. Spinal Cord Compression Caused by Fibroblastic Reticular Cell Tumor (FRCT) Originating from Thoracic Spine. World Neurosurg. 2020;141:20-4.
SEER Program (National Cancer Institute). SEER Hematolymphoid Database: Fibroblastic reticular cell tumor—Diagnostic criteria. Bethesda (MD): National Cancer Institute; [cited 2026 Jan 15]. Available from: https://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52f1/
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon (France): International Agency for Research on Cancer (IARC); 2013. Mesenchymal tumors and MSC differentiation
Lopez LV, Marker DF, Bailey N, et al. Soft tissue fibroblastic reticular cell tumor with whole-exome sequencing findings: an unexpected presentation of Lynch syndrome. AJSP: Reviews & Reports. 2019;24(6):288-91.
Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol. 2017;30(10):1433-42.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ulus Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.






